Sasha E Knowlton1, Alexandra I Gundersen2, Julia M Reilly3, Can Ozan Tan2, Jeffrey C Schneider4, Shirley L Shih2. 1. Spaulding Rehabilitation Hospital, Charlestown, Massachusetts; Harvard Medical School, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts. Electronic address: seknowlton@partners.org. 2. Spaulding Rehabilitation Hospital, Charlestown, Massachusetts; Harvard Medical School, Boston, Massachusetts; Massachusetts General Hospital, Boston, Massachusetts. 3. Memorial Sloan Kettering Cancer Center, New York, New York. 4. Spaulding Rehabilitation Hospital, Charlestown, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Abstract
OBJECTIVE: To obtain useful information for clinicians in evaluating patients with brain tumors for transfer to and subsequent care in inpatient rehabilitation facilities (IRFs). DESIGN: Retrospective chart review. SETTING: Inpatient rehabilitation facility. PARTICIPANTS: A total of 208 adults with either initial or recurrent brain tumors who were admitted to an IRF between January 2017 and December 2018 after an acute hospitalization. INTERVENTIONS: None MAIN OUTCOME MEASURES: Transfer from an IRF to an acute care hospital and mortality within 6 months from admission to an IRF. RESULTS: Of the 208 patients who met inclusion criteria, 20.2% were transferred to an acute care hospital during the IRF stay, which was associated with prior chemotherapy, steroid use, and laterality of tumor. In total, 36.9% of patients with brain tumors died within 6 months of an IRF admission that was associated with recurrent tumor diagnosis, prior chemotherapy, prior neurosurgical intervention, prior neurostimulant use, use of steroids, isocitrate dehydrogenase and O6-methyl-guanyl-methyl-transferase biomarkers, and laterality and location of tumor. CONCLUSIONS: Patients with brain tumors have a notable potential for acute hospital transfer and mortality within 6 months of IRF stay, with several tumor- and treatment-related risk factors. This information can help identify functional goals, identify high risk patients, enable closer clinical monitoring, and facilitate focused care discussions at IRFs.
OBJECTIVE: To obtain useful information for clinicians in evaluating patients with brain tumors for transfer to and subsequent care in inpatient rehabilitation facilities (IRFs). DESIGN: Retrospective chart review. SETTING: Inpatient rehabilitation facility. PARTICIPANTS: A total of 208 adults with either initial or recurrent brain tumors who were admitted to an IRF between January 2017 and December 2018 after an acute hospitalization. INTERVENTIONS: None MAIN OUTCOME MEASURES: Transfer from an IRF to an acute care hospital and mortality within 6 months from admission to an IRF. RESULTS: Of the 208 patients who met inclusion criteria, 20.2% were transferred to an acute care hospital during the IRF stay, which was associated with prior chemotherapy, steroid use, and laterality of tumor. In total, 36.9% of patients with brain tumors died within 6 months of an IRF admission that was associated with recurrent tumor diagnosis, prior chemotherapy, prior neurosurgical intervention, prior neurostimulant use, use of steroids, isocitrate dehydrogenase and O6-methyl-guanyl-methyl-transferase biomarkers, and laterality and location of tumor. CONCLUSIONS: Patients with brain tumors have a notable potential for acute hospital transfer and mortality within 6 months of IRF stay, with several tumor- and treatment-related risk factors. This information can help identify functional goals, identify high risk patients, enable closer clinical monitoring, and facilitate focused care discussions at IRFs.
Authors: Arash Asher; Pamela S Roberts; Catherine Bresee; Garret Zabel; Richard V Riggs; Andre Rogatko Journal: PM R Date: 2014-01-17 Impact factor: 2.298
Authors: Jacqueline M Mix; Carl V Granger; Michael J LaMonte; Paulette Niewczyk; Margaret A DiVita; Richard Goldstein; Jerome W Yates; Jo L Freudenheim Journal: Arch Phys Med Rehabil Date: 2017-02-01 Impact factor: 3.966
Authors: Erik H Hoyer; Dale M Needham; Jason Miller; Amy Deutschendorf; Michael Friedman; Daniel J Brotman Journal: Arch Phys Med Rehabil Date: 2013-06-26 Impact factor: 3.966
Authors: Jack B Fu; Henrique A Parsons; Ki Y Shin; Ying Guo; Benedict S Konzen; Rajesh R Yadav; Dennis W Smith Journal: Am J Phys Med Rehabil Date: 2010-03 Impact factor: 2.159